abnormal limb morphology, abnormal lung development, abnormal lung vasculature morphology, abnormal marginal zone B cell physiology, abnormal mesangial cell morphology, abnormal neuromuscular synapse morphology, abnormal placenta morphology, abnormal placental labyrinth vasculature morphology, abnormal podocyte morphology, abnormal pulmonary alveolus epithelium morphology, abnormal pulmonary alveolus morphology, abnormal renal glomerulus basement membrane morphology, abnormal right lung morphology, abnormal right subclavian artery morphology, abnormal thoracic cavity morphology, abnormal tooth development, abnormal trophoblast layer morphology, abnormal visceral pleura morphology, absent neurocranium, absent type I pneumocytes, absent ureter, atrioventricular septal defect, curly tail, decreased body size, decreased cell proliferation, decreased fetal size, decreased marginal zone B cell number, decreased placental labyrinth size, decreased transitional stage T2 B cell number, decreased type II pneumocyte number, dilated renal tubules, impaired basement membrane formation, impaired branching involved in ureteric bud morphogenesis, incomplete rostral neuropore closure, increased apoptosis, increased circulating creatinine level, increased fasting circulating glucose level, increased kidney apoptosis, increased renal glomerulus basement membrane thickness, increased transitional stage T1 B cell number, left pulmonary isomerism, lethality throughout fetal growth and development, complete penetrance, neonatal lethality, complete penetrance, overexpanded pulmonary alveoli, podocyte foot process effacement, postnatal lethality, incomplete penetrance, premature death, preweaning lethality, complete penetrance, renal/urinary system phenotype, small kidney, small lung, thin lung-associated mesenchyme